Pegavision Corporation Stock

Equities

6491

TW0006491004

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E. 06:00:00 2024-05-27 pm EDT 5-day change 1st Jan Change
468.5 TWD -1.58% Intraday chart for Pegavision Corporation -7.78% +18.16%
Sales 2024 * 7.58B 236M Sales 2025 * 8.79B 273M Capitalization 36.54B 1.14B
Net income 2024 * 2.17B 67.36M Net income 2025 * 2.56B 79.45M EV / Sales 2024 * 3.96 x
Net cash position 2024 * 6.5B 202M Net cash position 2025 * 8.51B 265M EV / Sales 2025 * 3.19 x
P/E ratio 2024 *
16.9 x
P/E ratio 2025 *
14.9 x
Employees -
Yield 2024 *
2.67%
Yield 2025 *
2.88%
Free-Float 52.31%
More Fundamentals * Assessed data
Dynamic Chart
Pegavision Corporation Announces Cash Dividends Payable on July 10, 2024 CI
Pegavision Corporation Approves Director Appointments CI
Pegavision Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Pegavision Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Pegavision Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Pegavision Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Pegavision Corporation announced that it expects to receive TWD 0.08 million in funding CI
Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Health Care Down on Mixed Earnings Prospects - Health Care Roundup DJ
Pegavision Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Pegavision Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Pegavision Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Pegavision Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
More news
1 day-1.58%
1 week-7.78%
Current month-10.59%
1 month-8.85%
3 months+16.40%
6 months+15.68%
Current year+18.16%
More quotes
1 week
465.00
Extreme 465
514.00
1 month
465.00
Extreme 465
548.00
Current year
368.00
Extreme 368
548.00
1 year
328.00
Extreme 328
548.00
3 years
270.50
Extreme 270.5
678.00
5 years
81.50
Extreme 81.5
678.00
10 years
63.71
Extreme 63.71
678.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 18-06-13
Director of Finance/CFO - 13-12-26
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 63 09-08-11
Chief Executive Officer - 18-06-13
Chairman - 09-08-11
More insiders
Date Price Change Volume
24-05-28 468.5 -1.58% 741,948
24-05-27 476 +0.11% 640,846
24-05-24 475.5 -1.04% 694,802
24-05-23 480.5 -4.09% 1,521,853
24-05-22 501 -1.96% 425,227

End-of-day quote Taiwan S.E., May 27, 2024

More quotes
Pegavision Corp is primarily engaged in the manufacture and sale of private brand contact lenses, as well as the original equipment manufacturing (OEM) business. The Company distributes its products within domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
468.5 TWD
Average target price
529.2 TWD
Spread / Average Target
+12.96%
Consensus